StockTipsArenaBeta

BUY Mankind Pharma Limited — ICICI Securities

BUYMankind Pharma Limited
Mankind Pharma share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred Swing (≤2wk))6 Jul 2026via Economic Times New Stock Recos

Entry₹2,535Inferred
Target₹2,655
Total upside +4.73% (call closed)
Stop lossNot given
At expiry₹2,480.817 Jul 2026, 3:30 pm
Expired-2.14%
Follow ICICI Securities for new calls(18% target hit, 22 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 17 Jul 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

5 advisors have active short-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jul · 1w ago

Neutral / worth noting (1)

Mankind Pharma Ltd's Board approved the incorporation of a wholly owned subsidiary in the Netherlands.

BSE · Company Update·11 Jul · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Mankind Pharma

All analyst calls on Mankind Pharma

More from ICICI Securities

Every call and its outcome